z-logo
open-access-imgOpen Access
Refined Crystal Structure of the Interleukin‐1 Receptor Antagonist
Author(s) -
Schreuder Herman A.,
Rondeau Jean Michel,
Tardif Chantal,
Soffientini Adolfo,
Sarubbi Edoardo,
Akeson Ann,
Bowlin Terry L.,
Yanofsky Stephen,
Barrett Ronald W.
Publication year - 1995
Publication title -
european journal of biochemistry
Language(s) - English
Resource type - Journals
eISSN - 1432-1033
pISSN - 0014-2956
DOI - 10.1111/j.1432-1033.1995.0838p.x
Subject(s) - interleukin 1 receptor antagonist , antagonist , receptor antagonist , interleukin 1 receptor , chemistry , receptor , pharmacology , interleukin , medicine , cytokine
Interleukin‐I (IL‐1) molecules are cytokines involved in the acute‐phase response against infection and injury. Three naturally occurring IL‐1 molecules are known, two agonists: IL‐1α and IL‐1β, and one antagonist, the 1L‐1 receptor antagonist (IL‐1ra). Although IL‐1 action protects the organism by enhancing the response to pathogens, its overproduction can lead to pathology and has been implicated in disease states that include septic shock, rheumatoid arthritis, graft versus host disease and certain leukemias. The crystal structure of IL‐1ra has been solved at 0.21‐nm resolution by molecular replacement using the IL‐1β structure as a search model. The crystals contain two independent IL‐1ra molecules which are very similar, IL‐1ra has the same fold as IL‐1α and IL‐1β. The fold consists of twelve β‐strands which form a six‐stranded β‐barrel, closed on one side by three β‐hairpin loops. Cys69 and Cys116 are linked via a disulfide bond and Pro53 has been built in the cisconformation. Comparison of the IL‐1ra structure with the IL‐1α and IL‐1β structures present in the Protein Data Bank shows that a putative receptor interaction region, involving the N‐terminus up to the beginning of strand β1 and the loops D and G, is very different in the three IL‐1 molecules. Other putative interaction regions, as identified with mutagenesis studies, are structurally conserved and rigid, allowing precise and specific interactions with the IL‐1 receptor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here